388 related articles for article (PubMed ID: 33313851)
1. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
Tanaka K; Ozaki T
Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
[TBL] [Abstract][Full Text] [Related]
2. What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?
Hindi N; Martin-Broto J
Curr Opin Oncol; 2021 Jul; 33(4):329-335. PubMed ID: 33973551
[TBL] [Abstract][Full Text] [Related]
3. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
[No Abstract] [Full Text] [Related]
4. The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
Iwamoto Y; Tanaka K
Jpn J Clin Oncol; 2012 Jun; 42(6):467-70. PubMed ID: 22628611
[TBL] [Abstract][Full Text] [Related]
5. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
O'Donnell PW; Manivel JC; Cheng EY; Clohisy DR
Clin Orthop Relat Res; 2014 Mar; 472(3):849-55. PubMed ID: 23640206
[TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.
Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159
[TBL] [Abstract][Full Text] [Related]
8. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
9. Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
Tanaka K; Ozaki T
Jpn J Clin Oncol; 2022 May; 52(6):526-530. PubMed ID: 35292817
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy in soft-tissue sarcomas?].
Sauer H
Strahlenther Onkol; 1995 Apr; 171(4):185-94. PubMed ID: 7740405
[TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment of upper extremity bone and soft tissue sarcomas.
Maples WJ; Buskirk SJ
Hand Clin; 2004 May; 20(2):vi, 221-5. PubMed ID: 15201026
[TBL] [Abstract][Full Text] [Related]
12. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant chemotherapy of soft tissue sarcoma].
Lévy E; Thirion P; Piedbois P
Cancer Radiother; 1997; 1(5):462-6. PubMed ID: 9587378
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of advanced bone and soft tissue sarcoma].
Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy in the treatment of sarcomas].
Fayette J; Blay JY
Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal treatment of sarcomas: standards and new aspects in pharmacological and radio-oncological treatment].
Lindner LH
Chirurg; 2019 Jun; 90(6):457-461. PubMed ID: 31053897
[TBL] [Abstract][Full Text] [Related]
19. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
